Receive our newsletter – data, insights and analysis delivered to you
  1. News
January 28, 2016

Sanofi collaborates with Iran Food and Drug Administration

French pharmaceutical firm Sanofi has signed a Memorandum of Cooperation (MoC) with the Iran Food and Drug Administration, affiliated to the Ministry of Health and Medical Education of Iran, in order to increase its presence in the country.

French pharmaceutical firm Sanofi has signed a Memorandum of Cooperation (MoC) with the Iran Food and Drug Administration, affiliated to the Ministry of Health and Medical Education of Iran, in order to increase its presence in the country.

The MoC is aimed at initiating talks to explore the possibilities where the company may provide its expertise for several projects, which will be studied to further develop existing local manufacturing collaborations and work on programmes to fight chronic and non-communicable diseases.

As part of the deal, the French firm would extend partnerships with local manufacturers to improve the sharing of its expertise in industrial quality standards and increase the transfer of pharmaceutical production technology and know-how.

The company will also collaborate with Iran’s Ministry of Health on programmes to avoid and control several chronic and non-communicable diseases, as well as on managing associated risk factors like diabetes.

"With this cooperation, we will consider the possibility to increase our footprint in Iran … and reinforce our ongoing industrial collaborations."

It will also evaluate potential collaborations to enhance the availability of exact epidemiological studies and registries.

The company noted that all assessments will be carried out in accordance with applicable laws, including trade restriction rules.

Content from our partners
Extractables and leachables analysis in pharmaceutical quality control
How Hengst helped to keep Germany’s charity “star singers” shining
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success

Sanofi board of directors chairman Serge Weinberg said: "With this cooperation, we will consider the possibility to increase our footprint in Iran, where we have been operating for more than ten years, and reinforce our ongoing industrial collaborations."

Both Sanofi and Iran Ministry of Health agree that the collaboration is critical to permit policy makers to create and shape effective and socially impactful policies in the health sector.

The deal will see Sanofi’s provide its extensive knowledge in epidemiological studies and registries on both national and international scales to the Ministry of Health, in order to help policy makers to address the chronic and non-communicable diseases areas such as diabetes, cardiovascular diseases, multiple sclerosis and rare diseases.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU